Header Logo

Connection

DAVID SHEIKH-HAMAD to Xenograft Model Antitumor Assays

Back to Details
This is a "connection" page, showing publications DAVID SHEIKH-HAMAD has written about Xenograft Model Antitumor Assays.
DAVID SHEIKH-HAMAD
Connection Strength
0.063
Xenograft Model Antitumor Assays
  1. Tolfenamic acid decreases c-Met expression through Sp proteins degradation and inhibits lung cancer cells growth and tumor formation in orthotopic mice. Invest New Drugs. 2011 Feb; 29(1):41-51.
    View in: PubMed
    Score: 0.063
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.